Merrimack Pharmaceuticals are dedicated to the discovery and development of innovative therapies for the treatment of autoimmune disease and cancer. Merrimack is advancing a robust pipeline of clinical and early-stage biologics that represent the next generation of patient-directed, targeted therapies.
Evolved Nanomaterial Sciences, Inc. is an emerging innovator in the field of chiral separations science.We have developed a number of unique and powerful technologies for the resolution of chiral molecules. ENS enables previously unattainable molecular separations, delivers unprecedented selectivity and scalability, and dramatically simplifies the research and analysis process. We have already expanded the chemical range of chiral chromatography to include low molecular weight compounds, commonly used in chiral synthesis, crystallographic resolution and analysis.
Caliper Life Sciences is a leading provider of cutting-edge technologies enabling researchers in the life sciences to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper has compiled numerous best-in-class solutions and is aggressively innovating new technologies to bridge the gaps that exist in bringing in vitro assays to in vivo results and ultimately into cures for human disease.
ARIAD is a-based biotechnology company focused on cancer. We are a cohesive team of talented people from diverse backgrounds with a shared vision: We seek to transform the lives of patients with breakthrough cancer medicines. This is our purpose. This is our passion. This is our promise.
3DM Inc. is a privately-held specialty biomaterials company, with a mission of developing novel medical therapies through its technologies for accelerating wound healing and tissue regeneration across a range of medical indications.
3DM’s medical devices provide a critical bridge in wound healing and tissue regeneration –a resorbable injectable nano-scale scaffold to accelerate ingrowth of normal local tissue.